BLS Pharmaceuticals
0
0
+€0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
20.69%Profit Margin
Profitable43.77MRevenue
9.05MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
BLS Pharmaceuticals Ltd. engages in the research, development, market and distribution of health products. It operates through the following segments: Wholesale, Plant Based, and Direct Sales. The Wholesale segment covers operation in United States of America (USA), and Asia. The Plant Based segment includes manufacturing, commercialization, and distribution of plant-based products. The Direct Sales segment focuses on Australia, and Asia operation. The company was founded in 1998 and is headquartered in Sydney, Australia.
Show More
CEO
Sam Watson
Country
Australia
ISIN
AU0000477796
WKN
000A42GCG
Listings
0 Comments
Share your thoughts
FAQs
What is BLS Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange BLS Pharmaceuticals stocks are traded under the ticker PR80.STU.
What is BLS Pharmaceuticals revenue for the last year?▼
BLS Pharmaceuticals revenue for the last year amounts to 43.77M EUR.
What is BLS Pharmaceuticals net income for the last year?▼
PR80.STU net income for the last year is 9.05M EUR.
In which sector is BLS Pharmaceuticals located?▼
BLS Pharmaceuticals operates in the Manufacturing sector.
When did BLS Pharmaceuticals complete a stock split?▼
The last stock split for BLS Pharmaceuticals was on June 24, 2026 with a ratio of 1:10.
Where is BLS Pharmaceuticals headquartered?▼
BLS Pharmaceuticals is headquartered in Sydney, Australia.